Overall Status

Recruiting (2)

Active, not recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

National Cancer Institute (NCI) (2)

City of Hope Medical Center (1)

Collaborator

Canadian Cancer Trials Group (1)

National Cancer Institute (NCI) (1)

Study Documents

Intervention Type

drug (3)

biological (2)

procedure (1)

Funder Type

NIH (2)

Other (1)

Study Type

Interventional (3)

metastatic papillary renal cell carcinoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic Papillary Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial (Atezolizumab, Cabozantinib S-malate)

Recruiting

Metastatic Papillary Renal Cell Carcinoma
Stage IV Renal Cell Cancer AJCC v8

Atezolizumab
+4 more

Sacramento, California
+38 more

Jan 17, 2023

Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte

Recruiting

Advanced Clear Cell Renal Cell Carcinoma
+11 more

Cabozantinib S-malate
+2 more

Duarte, California

City of Hope Medical Center

Nov 22, 2022

Locally Advanced Papillary Renal Cell Carcinoma, Metastatic Papillary Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7

Active, not recruiting

Locally Advanced Papillary Renal Cell Carcinoma
+6 more

Cabozantinib S-malate
+3 more

Anchorage, Alaska
+596 more

Aug 2, 2022